Samia Harbi

1.7k total citations
40 papers, 561 citations indexed

About

Samia Harbi is a scholar working on Hematology, Immunology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Samia Harbi has authored 40 papers receiving a total of 561 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Hematology, 15 papers in Immunology and 12 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Samia Harbi's work include Hematopoietic Stem Cell Transplantation (35 papers), Acute Myeloid Leukemia Research (12 papers) and Acute Lymphoblastic Leukemia research (12 papers). Samia Harbi is often cited by papers focused on Hematopoietic Stem Cell Transplantation (35 papers), Acute Myeloid Leukemia Research (12 papers) and Acute Lymphoblastic Leukemia research (12 papers). Samia Harbi collaborates with scholars based in France, Italy and United States. Samia Harbi's co-authors include Didier Blaise, Christian Chabannon, Luca Castagna, Sabine Fürst, Angéla Granata, Catherine Faucher, Raynier Devillier, Stéfania Bramanti, Norbert Vey and Bilal Mohty and has published in prestigious journals such as Blood, Cancer and Frontiers in Immunology.

In The Last Decade

Samia Harbi

36 papers receiving 556 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Samia Harbi France	14	485	272	179	140	58	40	561
Melissa Sanacore United States	5	365 0.8×	164 0.6×	155 0.9×	82 0.6×	60 1.0×	13	385
Connie A. Sizemore United States	9	767 1.6×	351 1.3×	279 1.6×	213 1.5×	97 1.7×	26	817
Sergey N. Bondarenko Russia	9	335 0.7×	144 0.5×	112 0.6×	132 0.9×	43 0.7×	117	466
K-S Eom South Korea	13	442 0.9×	135 0.5×	103 0.6×	222 1.6×	67 1.2×	19	529
Feng‐Rong Wang China	12	453 0.9×	186 0.7×	144 0.8×	154 1.1×	31 0.5×	20	509
Jesse Levin United States	4	449 0.9×	296 1.1×	111 0.6×	59 0.4×	73 1.3×	6	558
Marie-Térèse Little United States	10	476 1.0×	212 0.8×	107 0.6×	93 0.7×	69 1.2×	11	550
Sandeep Nagra United Kingdom	13	351 0.7×	134 0.5×	143 0.8×	108 0.8×	31 0.5×	21	518
Elena V. Babenko Russia	9	195 0.4×	130 0.5×	106 0.6×	56 0.4×	42 0.7×	45	324

Countries citing papers authored by Samia Harbi

Since Specialization

Citations

This map shows the geographic impact of Samia Harbi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samia Harbi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samia Harbi more than expected).

Fields of papers citing papers by Samia Harbi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samia Harbi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samia Harbi. The network helps show where Samia Harbi may publish in the future.

Co-authorship network of co-authors of Samia Harbi

This figure shows the co-authorship network connecting the top 25 collaborators of Samia Harbi. A scholar is included among the top collaborators of Samia Harbi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samia Harbi. Samia Harbi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fürst, Sabine, Boris Calmels, Thomas Pagliardini, et al.. (2023). GVHD prophylaxis with post-transplant cyclophosphamide results in lower incidence of GVHD and allows faster immunosuppressive treatment reduction compared to antithymocyte globulin in 10/10 HLA-matched unrelated allogeneic hematopoietic cell transplantation. Bone Marrow Transplantation. 58(11). 1179–1181. 2 indexed citations

Harbi, Samia, Sylvain Garciaz, Thomas Pagliardini, et al.. (2023). Peripheral blood haploidentical hematopoietic cell transplantation for patients aged 70 years and over with acute myeloid leukemia or high-risk myelodysplastic syndrome. Bone Marrow Transplantation. 59(1). 101–106. 8 indexed citations

Devillier, Raynier, Pierre Jean Weiller, Jean‐Marc Schiano de Colella, et al.. (2023). Life-threatening toxicities upon Pembrolizumab intake: could pharmacokinetics be the bad guy?. Cancer Chemotherapy and Pharmacology. 93(6). 627–632. 2 indexed citations

Castagna, Luca, Thomas Pagliardini, Stéfania Bramanti, et al.. (2020). Allogeneic stem cell transplantation in poor prognosis peripheral T-cell lymphoma: the impact of different donor type on outcome. Bone Marrow Transplantation. 56(4). 883–889. 6 indexed citations

Granata, Angéla, Thomas Pagliardini, Luca Castagna, et al.. (2019). Posttransplantation cyclophosphamide vs. antithymocyte globulin as GVHD prophylaxis for mismatched unrelated hematopoietic stem cell transplantation. Bone Marrow Transplantation. 55(2). 349–355. 18 indexed citations

Mariotti, Jacopo, Raynier Devillier, Stéfania Bramanti, et al.. (2019). Peripheral Blood Stem Cells versus Bone Marrow for T Cell–Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide in Hodgkin Lymphoma. Biology of Blood and Marrow Transplantation. 25(9). 1810–1817. 13 indexed citations

Pagliardini, Thomas, Samia Harbi, Sabine Fürst, et al.. (2018). Post-transplantation cyclophosphamide-based haploidentical versus Atg-based unrelated donor allogeneic stem cell transplantation for patients younger than 60 years with hematological malignancies: a single-center experience of 209 patients. Bone Marrow Transplantation. 54(7). 1067–1076. 19 indexed citations

Faucher, Catherine, Christian Chabannon, Sabine Fürst, et al.. (2018). Cost-effectiveness analysis of haploidentical vs matched unrelated allogeneic hematopoietic stem cells transplantation in patients older than 55 years. Bone Marrow Transplantation. 53(9). 1096–1104. 17 indexed citations

Devillier, Raynier, Faézeh Legrand, Jérôme Rey, et al.. (2018). HLA-Matched Sibling versus Unrelated versus Haploidentical Related Donor Allogeneic Hematopoietic Stem Cell Transplantation for Patients Aged Over 60 Years with Acute Myeloid Leukemia: A Single-Center Donor Comparison. Biology of Blood and Marrow Transplantation. 24(7). 1449–1454. 30 indexed citations

10.

Mariotti, Jacopo, Raynier Devillier, Stéfania Bramanti, et al.. (2017). T Cell-Replete Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for Hodgkin Lymphoma Relapsed after Autologous Transplantation: Reduced Incidence of Relapse and of Chronic Graft-versus-Host Disease Compared with HLA-Identical Related Donors. Biology of Blood and Marrow Transplantation. 24(3). 627–632. 32 indexed citations

11.

Bramanti, Stéfania, Samia Harbi, Sabine Fürst, et al.. (2017). Killer Cell Immunoglobulin-Like Receptor–Ligand Mismatch in Donor versus Recipient Direction Provides Better Graft-versus-Tumor Effect in Patients with Hematologic Malignancies Undergoing Allogeneic T Cell–Replete Haploidentical Transplantation Followed by Post-Transplant Cyclophosphamide. Biology of Blood and Marrow Transplantation. 24(3). 549–554. 39 indexed citations

12.

Harbi, Samia, Raynier Devillier, Stéfania Bramanti, et al.. (2017). Haploidentical Hematopoietic Stem Cell Allogeneic Transplantation with High Dose Post Transplantation Cyclophosphamide for Patients over 60 Years of Age. Blood. 130. 2035–2035. 1 indexed citations

13.

Crocchiolo, Roberto, Sabine Fürst, Angéla Granata, et al.. (2016). The efficacy and safety of a new reduced-toxicity conditioning with 4 days of once-daily 100 mg/m²intravenous busulfan associated with fludarabine and antithymocyte globulins prior to allogeneic stem cell transplantation in patients with high-risk myelodysplastic syndrome or acute leukemia. Leukemia & lymphoma. 57(10). 2315–2320. 4 indexed citations

14.

Blaise, Didier, Sabine Fürst, Roberto Crocchiolo, et al.. (2015). Haploidentical T Cell–Replete Transplantation with Post-Transplantation Cyclophosphamide for Patients in or above the Sixth Decade of Age Compared with Allogeneic Hematopoietic Stem Cell Transplantation from an Human Leukocyte Antigen–Matched Related or Unrelated Donor. Biology of Blood and Marrow Transplantation. 22(1). 119–124. 61 indexed citations

15.

Cheikh, Jean El, Roberto Crocchiolo, Sabine Fürst, et al.. (2015). Unrelated cord blood compared with haploidentical grafts in patients with hematological malignancies. Cancer. 121(11). 1809–1816. 27 indexed citations

16.

Crocchiolo, Roberto, Luca Castagna, Sabine Fürst, et al.. (2015). The Role of Donor CMV Serostatus on Outcome after T-Cell Replete Haplo-SCT and Post-Transplant Cyclophosphamide: A Cohort Analysis on 207 Consecutive Adult Patients. Blood. 126(23). 4401–4401. 2 indexed citations

17.

Castagna, Luca, Roberto Crocchiolo, Sabine Fürst, et al.. (2014). Bone Marrow Compared with Peripheral Blood Stem Cells for Haploidentical Transplantation with a Nonmyeloablative Conditioning Regimen and Post-transplantation Cyclophosphamide. Biology of Blood and Marrow Transplantation. 20(5). 724–729. 116 indexed citations

18.

Fürst, Sabine, E. Bernit, Jean El Cheikh, et al.. (2014). Successfull Engraftment and Clearance of Donor Specific Antibodies after Haploidentical Related Stem Cell Transplantation for an Adult Patient with Sickle Cell Disease. Blood. 124(21). 5792–5792. 1 indexed citations

19.

Devillier, Raynier, Sabine Fürst, Roberto Crocchiolo, et al.. (2013). Reduced Intensity Conditioning Based On Fludarabine, Intravenous Busulfan (2 Days) and Antithymocyte Globulins (2 Days) Results In High Disease Free Survival Without Persisting Gvhd In Patients Transplanted For Hematological Malignancies: Large Single Center Cohort With Long Follow-Up. Blood. 122(21). 3364–3364. 1 indexed citations

20.

Devillier, Raynier, Sabine Fürst, Jean El Cheikh, et al.. (2013). Antithymocyte Globulin in Reduced-Intensity Conditioning Regimen Allows a High Disease-Free Survival Exempt of Long-Term Chronic Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation. 20(3). 370–374. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact